华仁药业: 董事会决议公告

Meeting Overview - The eighth board meeting of Huaren Pharmaceutical Co., Ltd. was held on August 14, 2025, combining in-person and online formats, with all nine directors present [1] - The meeting complied with legal regulations and the company's articles of association [1] Resolutions Passed - The board approved the "2025 Half-Year Report" and its summary, confirming that the report accurately reflects the company's financial status and operational performance for the first half of 2025, with no false statements or omissions [2][3] - The board approved amendments to the company's articles of association to align with the latest legal requirements and improve corporate governance [2][3] - The board approved the formulation and revision of certain company policies to enhance governance structures in accordance with updated regulations [3][4] - The board agreed to the nomination of independent directors, Fan Yingjie and Wang Zhenjie, to the eighth board, pending approval at the upcoming shareholders' meeting [5][6] - The board scheduled the first temporary shareholders' meeting for September 1, 2025, at 14:00 in the company meeting room [6][7]